Furthermore, studies suggest that the reduction of IL-1β and inhibition of the NLRP3 inflammasome could impair the anti-viral immune response, exposing patients with IL-1β and NLRP3 inhibition to a more severe course of a viral infection than those without. Here, NLRP3 is linked to viral infectious disease.